Top Stocks to Buy in India: Expert Picks and Market Analysis
Discover the top stocks to buy in India, as recommended by leading market analysts, along with expert analysis and insights to inform your investment decisions.
Your blog category
Discover the top stocks to buy in India, as recommended by leading market analysts, along with expert analysis and insights to inform your investment decisions.
CLSA report suggests Indus Towers is poised to benefit the most from Vodafone Idea’s potential revival, with a high conviction outperform rating and a target price of Rs 565.
Silver has crossed the $90 per ounce milestone, reaching a market capitalization of $5.038 trillion. We analyze the factors driving this surge and what it means for Indian investors.
Tata Elxsi shares fell despite a strong Q3 earnings report. Find out what’s behind the decline and what it means for Indian investors.
Polycab India Ltd.’s share price extends decline for the fifth session after a significant block trade of $135 million on the National Stock Exchange, signaling strong institutional activity in the cable manufacturer’s shares.
Coal India’s share price has surged to a two-month high on the back of its arm Bharat Coking Coal Ltd’s (BCCL) record-breaking IPO. Here’s what’s driving the rally and what it means for Indian investors.
Get the latest updates on Infosys Q3 results, including revenue growth, operating profit, and EBIT margin expectations. What do the results mean for Indian investors?
ICICI Prudential Life Insurance Company Ltd.’s Q3 results show a steady VNB margin of 24.4%, driven by product mix shift and cost optimization. Check the latest target price and analysis.
Bank of Maharashtra’s Q3 results have sent its shares soaring to a 17-month high. But what do the numbers really mean for investors, and how can you make the most of this trend?
ICICI Prudential Life’s Q3 performance was marked by resilient margins, offsetting soft premium growth, despite GST and persistency challenges. Brokerages remain positive, citing stable margins and gradual normalization in APE growth.